On 17 February, Ignyta, Inc. (NASDAQ:RXDX), announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Ignyta’s lead product candidate entrectinib for the treatment of TrkA-positive, TrkB-positive, TrkC-positive, ROS1-positive or ALK-positive colorectal cancer. On Wednesday shares of Ignyta, Inc. (NASDAQ:RXDX) closed at $8.51.
JD.com, Inc. (NASDAQ:JD), announced that it plans to release its unaudited fourth quarter and full year 2014 financial results on Tuesday, March 3, 2015, before the market opens. JD.com, Inc. (NASDAQ:JD) in last trading activity moved down -0.69% to close at $27.30. Company weekly performance is -2.50% while its quarterly performance stands at 13.37%. JD.com, Inc. (NASDAQ:JD) is -17.52% away from its 52 week high.
Eni SpA (NYSE:E) was downgraded by Jefferies Group from a “hold” rating to an “underperform” rating in a research note issued on Tuesday, TheFlyOnTheWall.com reports. On last trading day Eni SpA (NYSE:E) moved down -0.19% to close at $37.62. Its volatility for the week is 1.62% while volatility for the month is 1.73%. E’s sales growth for past 5 years was 1.00% and its EPS growth for past 5 years was -10.10%. Eni SpA (NYSE:E) monthly performance is 9.84%.
Ocean Rig UDW Inc. (NASDAQ:ORIG) reported weaker-than-expected earnings for the fourth quarter. However, the company’s revenue exceeded analysts’ estimates. The Nicosia, Cyprus-based company reported a quarterly net income of $87.5 million, or $0.66 per share, compared to $39.7 million, or $0.30 per share, in the year-ago period. Ocean Rig UDW Inc. (NASDAQ:ORIG) institutional ownership stands at 33.80%. In last trading activity company’s stock closed at $8.28.
salesforce.com Inc. NYSE: CRM) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came rose 26% to $1.44 billion versus the consensus estimate of $1.44 billion. On last trading day salesforce.com, inc. (NYSE:CRM) moved up 1.52% to close at $62.87. Its volatility for the week is 1.78% while volatility for the month is 2.29%. CRM’s sales growth for past 5 years was 30.50% and its EPS growth for past 5 years was -44.70%. salesforce.com, inc. (NYSE:CRM) monthly performance is 5.17%.